Cabio Biotech (Wuhan) Co., Ltd.

52
Hold
  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: CNE100005X31
CNY
22.89
-0.08 (-0.35%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Operating Income
550.00
437.00
428.00
346.00
318.00
306.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
550.00
437.00
428.00
346.00
318.00
306.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
0.00
0.00
1.00
0.00
0.00
0.00
General and Administration Expenses
63.00
60.00
77.00
46.00
43.00
41.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
428.00
357.00
363.00
254.00
211.00
208.00
Operating Profit (PBDIT) excl Other Income
121.00
79.00
65.00
91.00
107.00
97.00
Other Income
36.00
37.00
63.00
56.00
56.00
51.00
Operating Profit (PBDIT)
197.00
155.00
151.00
177.00
183.00
169.00
Interest
0.00
0.00
1.00
0.00
0.00
0.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
58.00
50.00
27.00
24.00
26.00
28.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
139.00
102.00
84.00
153.00
160.00
140.00
Provision for Tax
19.00
13.00
16.00
20.00
22.00
19.00
Profit After Tax
124.00
91.00
64.00
128.00
130.00
118.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
0.74
0.54
0.38
0.77
0.78
0.70
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 25.77% vs 2.00% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 51.90% vs 21.26% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -25.80% vs -45.60% in Dec 2023

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2024 is 35.94% vs 41.95% in Dec 2023

Compare Profit and Loss Results of Cabio Biotech (Wuhan) Co., Ltd.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
No of Months
12
12
Operating Income
550.00
0
550.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
550.00
0
550.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0
0.00
0%
Raw Materials Consumed
0.00
0
0.00
0%
Power & Fuel Cost
0.00
0
0.00
0%
Employee Cost
0.00
0
0.00
0%
Operating Expenses
0.00
0
0.00
0%
General and Administration Expenses
63.00
0
63.00
0%
Selling and Distribution Expenses
0.00
0
0.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
0.00
0
0.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
428.00
0
428.00
0%
Operating Profit (PBDIT) excl Other Income
121.00
0.00
121.00
0%
Other Income
36.00
0
36.00
0%
Operating Profit (PBDIT)
197.00
0
197.00
0%
Interest
0.00
0
0.00
0%
Profit before Depriciation and Tax
0.00
0
0.00
0%
Depreciation
58.00
0
58.00
0%
Profit Before Taxation & Exceptional Items
0.00
0
0.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
139.00
0
139.00
0%
Provision for Tax
19.00
0
19.00
0%
Profit After Tax
124.00
0
124.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
0.00
0
0.00
0%
Profit Available for appropriations
0.00
0
0.00
0%
Appropriations
0.00
0
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
0.74
0
0.74
0%
Profit And Loss - Net Sales
Net Sales 550.15 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 25.77% vs 2.00% in Dec 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 121.23 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 51.90% vs 21.26% in Dec 2023

Profit And Loss - Interest
Interest 0.57 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -25.80% vs -45.60% in Dec 2023

Profit And Loss - Profit After Tax
Profit After Tax 124.21 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 35.94% vs 41.95% in Dec 2023